Loading clinical trials...
Loading clinical trials...
Interventional, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Delayed-Start Study to Evaluate the Efficacy and Safety of Eptinezumab in Patients With Episodic Cluster Headache
Conditions
Interventions
Eptinezumab
Placebo
Locations
120
United States
Barrow Neurological Institute
Phoenix, Arizona, United States
Mayo Clinic in Arizona - Phoenix Campus
Phoenix, Arizona, United States
Keck School of Medicine of USC
Los Angeles, California, United States
Clinical Research Institute
Los Angeles, California, United States
Stanford Neurosciences Health Center
Palo Alto, California, United States
Neurology Colorado - Denver Advanced Neurological Evaluation and Treatment Center
Denver, Colorado, United States
Start Date
December 23, 2020
Primary Completion Date
June 14, 2023
Completion Date
October 5, 2023
Last Updated
August 9, 2024
Lead Sponsor
H. Lundbeck A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions